Log In
BCIQ
Print this Print this
 

Vasoactive intestinal peptide receptor 2 (VPAC2)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Vasoactive intestinal peptide receptor 2 (VPAC2)

BCIQ
Print ChartPrint this
Marketed, 1 Phase I, 1 Phase I, 1 Preclinical, 1
Phase of DevelopmentPreclinicalPhase IMarketed
Cardiovascular

1

1

-

Genitourinary

-

-

1

Musculoskeletal

-

1

-




 Products Targeting Vasoactive intestinal peptide receptor 2 (VPAC2)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$789.0M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/04/2015

$789.0M

0

0

02/15/2010

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury Trial today